Diverse effects of zinc on NF-κB and AP-1 transcription factors: Implications for prostate cancer progression

Carcinogenesis

Volumn 27, Issue 10, 2006, Pages 1980-1990

  Uzzo, Robert G ^a   Crispen, Paul L ^a   Golovine, Konstantin ^a   Makhov, Peter ^a   Horwitz, Eric M ^a   Kolenko, Vladimir M ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; ZINC;

ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING SITE; CANCER CELL CULTURE; CANCER INVASION; CARCINOGENESIS; CELL ADHESION; CHELATION; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE COURSE; ENZYME DEGRADATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; PROSTATE CANCER; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

CELL ADHESION; CELL LINE, TUMOR; CYTOKINE RECEPTOR GP130; DISEASE PROGRESSION; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; NF-KAPPA B; PROSTATIC NEOPLASMS; TRANSCRIPTION FACTOR AP-1; VASCULAR ENDOTHELIAL GROWTH FACTOR A; ZINC;

EID: 33745493746     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgl034     Document Type: Article

References (64)

1. Feng,P., Li,T.L., Guan,Z.X., Franklin,R.B. and Costello,L.C. (2002) Direct effect of zinc on mitochondrial apoptogenesis in prostate cells. Prostate, 52, 311-318.
2. Costello,L.C. and Franklin,R.B. (1998) Novel role of zinc in the regulation of prostate citrate metabolism and its implications in prostate cancer. Prostate, 35, 285-296.
3. Liang,J.Y., Liu,Y.Y., Zou,J., Franklin,R.B., Costello,L.C. and Feng,P. (1999) Inhibitory effect of zinc on human prostatic carcinoma cell growth. Prostate, 40, 200-207.
4. Ogunlewe,J.O. and Osegbe,D.N. (1989) Zinc and cadmium concentrations in indigenous blacks with normal, hypertrophic, and malignant prostate. Cancer, 63, 1388-1392.
5. Zaichick,V., Sviridova,T.V. and Zaichick,S.V. (1997) Zinc in the human prostate gland: Normal, hyperplastic and cancerous. Int. Urol. Nephrol., 29, 565-574.
6. Costello,L.C., Liu,Y., Zou,J. and Franklin,R.B. (1999) Evidence for a zinc uptake transporter in human prostate cancer cells which is regulated by prolactin and testosterone. J. Biol. Chem., 274, 17499-17504.
7. Suh,J. and Rabson,A.B. (2004) NF-kappaB activation in human prostate cancer: Important mediator or epiphenomenon? J. Cell. Biochem., 91, 100-117.
8. Suh,J., Payvandi,F., Edelstein,L.C., Amenta,P.S., Zong,W.X., Gelinas,C. and Rabson,A.B. (2002) Mechanisms of constitutive NF-kappaB activation in human prostate cancer cells. Prostate, 52, 183-200.
9. Sweeney,C., Li,L., Shanmugam,R., Bhat-Nakshatri,P., Jayaprakasan,V., Baldridge,L.A., Gardner,T., Smith,M., Nakshatri,H. and Cheng,L. (2004) Nuclear factor-kappaB is constitutively activated in prostate cancer in vitro and is overexpressed in prostatic intraepithelial neoplasia and adenocarcinoma of the prostate. Clin. Cancer Res., 10, 5501-5507.
10. Eferl,R. and Wagner,E.F. (2003) AP-1: A double-edged sword in tumorigenesis. Nat. Rev. Cancer, 3, 859-868.
11. Shukla,S., Maclennan,G.T., Marengo,S.R., Resnick,M.I. and Gupta,S. (2005) Constitutive activation of PI3K-Akt and NF-kappaB during prostate cancer progression in autochthonous transgenic mouse model. Prostate, 64, 224-239.
12. Kudrin,A.V. (2000) Trace elements in regulation of NF-kappaB activity. J. Trace Elem. Med. Biol., 14, 129-142.
13. Kim,C.H., Kim,J.H., Lee,J., Hsu,C.Y. and Ahn,Y.S. (2003) Thiol antioxidant reversal of pyrrolidine dithiocarbamate-induced reciprocal regulation of AP-1 and NF-kappaB. Biol. Chem., 384, 143-150.
14. Kim,C.H., Kim,J.H., Lee,J. and Ahn,Y.S. (2003) Zinc-induced NF-kappaB inhibition can be modulated by changes in the intracellular metallothionein level. Toxicol. Appl. Pharmacol., 190, 189-196.
15. Galaris,D. and Evangelou,A. (2002) The role of oxidative stress in mechanisms of metal-induced carcinogenesis. Crit. Rev. Oncol. Hematol., 42, 93-103.
16. Ho,E. and Ames,B.N. (2002) Low intracellular zinc induces oxidative DNA damage, disrupts p53, NFkappa B, and AP1 DNA binding, and affects DNA repair in a rat glioma cell line. Proc. Natl Acad. Sci. USA, 99, 16770-16775.
17. Hellmuth,M., Wetzler,C., Nold,M., Chang,J.H., Frank,S., Pfeilschifter,J. and Muhl,H. (2002) Expression of interleukin-8, heme oxygenase-1 and vascular endothelial growth factor in DLD-1 colon carcinoma cells exposed to pyrrolidine dithiocarbamate. Carcinogenesis, 23, 1273-1279.
18. Connell,P., Young,V.M., Toborek,M., Cohen,D.A., Barve,S., McClain,C.J. and Hennig,B. (1997) Zinc attenuates tumor necrosis factor-mediated activation of transcription factors in endothelial cells. J. Am. Coll. Nutr., 16, 411-417.
19. Meerarani,P., Reiterer,G., Toborek,M. and Hennig,B. (2003) Zinc modulates PPARgamma signaling and activation of porcine endothelial cells. J. Nutr., 133, 3058-3064.
20. Ondrey,F.G., Dong,G., Sunwoo,J., Chen,Z., Wolf,J.S., Crowl-Bancroft,C.V., Mukaida,N. and Van Waes,C. (1999) Constitutive activation of transcription factors NF-(kappa)B, AP-1, and NF-IL6 in human head and neck squamous cell carcinoma cell lines that express pro-inflammatory and pro-angiogenic cytokines. Mol. Carcinog., 26, 119-129.
21. Huang,S., Pettaway,C.A., Uehara,H., Bucana,C.D. and Fidler,I.J. (2001) Blockade of NF-kappaB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis. Oncogene, 20, 4188-4197.
22. Huang,Q., Shen,H.M. and Ong,C.N. (2004) Inhibitory effect of emodin on tumor invasion through suppression of activator protein-1 and nuclear factor-kappaB. Biochem. Pharmacol., 68, 361-371.
23. Bancroft,C.C., Chen,Z., Yeh,J., Sunwoo,J.B., Yeh,N.T., Jackson,S., Jackson,C. and Van Waes,C. (2002) Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-kappaB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines. Int. J. Cancer, 99, 538-548.
24. Yuspa,S.H. (1998) The pathogenesis of squamous cell cancer: Lessons learned from studies of skin carcinogenesis. J. Dermatol. Sci., 17, 1-7.
25. Malliri,A., Symons,M., Hennigan,R.F., Hurlstone,A.F., Lamb,R.F., Wheeler,T. and Ozanne,B.W. (1998) The transcription factor AP-1 is required for EGF-induced activation of rho-like GTPases, cytoskeletal rearrangements, motility, and in vitro invasion of A431 cells. J. Cell. Biol., 143, 1087-1099.
26. Dong,Z., Crawford,H.C., Lavrovsky,V., Taub,D., Watts,R., Matrisian,L.M. and Colburn,N.H. (1997) A dominant negative mutant of jun blocking 12-O-tetradecanoylphorbol-13-acetate-induced invasion in mouse keratinocytes. Mol. Carcinog., 19, 204-212.
27. Ozanne,B.W., McGarry,L., Spence,H.J., Johnston,I., Winnie,J., Meagher,L. and Stapleton,G. (2000) Transcriptional regulation of cell invasion: AP-1 regulation of a multigenic invasion programme. Eur. J. Cancer, 36, 1640-1648.
28. Gilmore,T.D. (1999) The Rel/NF-kappaB signal transduction pathway: introduction. Oncogene, 18, 6842-6844.
29. Pahl,H.L. (1999) Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene, 18, 6853-6866.
30. Nakashima,J., Tachibana,M., Ueno,M., Miyajima,A., Baba,S. and Murai,M. (1998) Association between tumor necrosis factor in serum and cachexia in patients with prostate cancer. Clin. Cancer Res., 4, 1743-1748.
31. Jochum,W., Passegue,E. and Wagner,E.F. (2001) AP-1 in mouse development and tumorigenesis. Oncogene, 20, 2401-2412.
32. Marreiros,A., Dudgeon,K., Dao,V., Grimm,M.O., Czolij,R., Crossley,M. and Jackson,P. (2005) KAI1 promoter activity is dependent on p53, junB and AP2: Evidence for a possible mechanism underlying loss of KAI1 expression in cancer cells. Oncogene, 24, 637-649.
33. Kustikova,O., Kramerov,D., Grigorian,M., Berezin,V., Bock,E., Lukanidin,E. and Tulchinsky,E. (1998) Fra-1 induces morphological transformation and increases in vitro invasiveness and motility of epithelioid adenocarcinoma cells. Mol. Cell. Biol., 18, 7095-7105.
34. Edwards,J., Krishna,N.S., Mukherjee,R. and Bartlett,J.M. (2004) The role of c-Jun and c-Fos expression in androgen-independent prostate cancer. J. Pathol., 204, 153-158.
35. Zerbini,L.F., Wang,Y., Cho,J.Y. and Libermann,T.A. (2003) Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer. Cancer Res., 63, 2206-2215.
36. Mukhopadhyay,A., Bueso-Ramos,C., Chatterjee,D., Pantazis,P. and Aggarwal,B.B. (2001) Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines. Oncogene, 20, 7597-7609.
37. Kolenko,V., Bloom,T., Rayman,P., Bukowski,R., Hsi,E. and Finke,J. (1999) Inhibition of NF-kappa B activity in human T lymphocytes induces caspase-dependent apoptosis without detectable activation of caspase-1 and -3. J Immunol., 163, 590-598.
38. Uzzo,R.G., Leavis,P., Hatch,W., Gabai,V.L., Dulin,N., Zvartau,N. and Kolenko,V.M. (2002) Zinc inhibits nuclear factor-kappaB activation and sensitizes prostate cancer cells to cytotoxic agents. Clin. Cancer Res., 8, 3579-3583.
39. Schulze-Osthoff,K., Ferrari,D., Riehemann,K. and Wesselborg,S. (1997) Regulation of NF-kappa B activation by MAP kinase cascades. Immunobiology, 198, 35-49.
40. Whitmarsh,A.J. and Davis,R.J. (1996) Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J. Mol. Med., 74, 589-607.
41. Lee,F.S., Hagler,J., Chen,Z.J. and Maniatis,T. (1997) Activation of the IkappaB alpha kinase complex by MEKK1, a kinase of the JNK pathway. Cell, 88, 213-222.
42. Shimada,K., Nakamura,M., Ishida,E., Kishi,M. and Konishi,N. (2003) Roles of p38- and c-jun NH2-terminal kinase-mediated pathways in 2-methoxyestradiol-induced p53 induction and apoptosis. Carcinogenesis, 24, 1067-1075.
43. Ferrer,F.A., Miller,L.J., Andrawis,R.I., Kurtzman,S.H., Albertsen,P.C., Laudone,V.P. and Kreutzer,D.L. (1998) Angiogenesis and prostate cancer: in vivo and in vitro expression of angiogenesis factors by prostate cancer cells. Urology, 51, 161-167.
44. Aalinkeel,R., Nair,M.P., Sufrin,G., Mahajan,S.D., Chadha,K.C., Chawda,R.P. and Schwartz,S.A. (2004) Gene expression of angiogenic factors correlates with metastatic potential of prostate cancer cells. Cancer Res., 64, 5311-5321.
45. Strohmeyer,D., Rossing,C., Bauerfeind,A., Kaufmann,O., Schlechte,H., Bartsch,G. and Loening,S. (2000) Vascular endothelial growth factor and its correlation with angiogenesis and p53 expression in prostate cancer. Prostate, 45, 216-224.
46. Hu,X., Janssen,W.E., Moscinski,L.C., Bryington,M., Dangsupa,A., Rezai-Zadeh,N., Babbin,B.A. and Zuckerman,K.S. (2001) An IkappaBalpha inhibitor causes leukemia cell death through a p38 MAP kinasedependent, NF-kappaB-independent mechanism. Cancer Res., 61, 6290-6206.
47. Tozawa,K., Sakurada,S., Kohri,K. and Okamoto,T. (1995) Effects of antinuclear factor kappa B reagents in blocking adhesion of human cancer cells to vascular endothelial cells. Cancer Res., 55, 4162-4167.
48. Farina,A.R., Cappabianca,L., Mackay,A.R., Tiberio,A., Tacconelli,A., Tessitore,A., Frati,L., Martinotti,S. and Gulino,A. (1997) Transcriptional regulation of intercellular adhesion molecule 1 by phorbol ester in human neuroblastoma cell line SK-N-SH involves jun- and fos-containing activator protein 1 site binding complex(es). Cell Growth Differ., 8, 789-800.
49. Gho,Y.S., Kim,P.N., Li,H.C., Elkin,M. and Kleinman,H.K. (2001) Stimulation of tumor growth by human soluble intercellular adhesion molecule-1. Cancer Res., 61, 4253-4257.
50. Adler,H.L., McCurdy,M.A., Kattan,M.W., Timme,T.L., Scardino,P.T. and Thompson,T.C. (1999) Elevated levels of circulating interleukin-6 and transforming growth factor-beta1 in patients with metastatic prostatic carcinoma. J. Urol., 161, 182-187.
51. Chung,T.D., Yu,J.J., Spiotto,M.T., Bartkowski,M. and Simons,J.W. (1999) Characterization of the role of IL-6 in the progression of prostate cancer. Prostate, 38, 199-207.
52. Chen,T., Wang,L.H. and Farrar,W.L. (2000) Interleukin 6 activates androgen receptor-mediated gene expression through a signal transducer and activator of transcription 3-dependent pathway in LNCaP prostate cancer cells. Cancer Res., 60, 2132-2135.
53. Palmer,J., Ernst,M., Hammacher,A. and Hertzog,P.J. (2005) Constitutive activation of gp130 leads to neuroendocrine differentiation in vitro and in vivo. Prostate, 62, 282-289.
54. Shumilla,J.A., Wetterhahn,K.E. and Barchowsky,A. (1998) Inhibition of NF-kappa B binding to DNA by chromium, cadmium, mercury, zinc, and arsenite in vitro: Evidence of a thiol mechanism. Arch. Biochem. Biophys., 349, 356-362.
55. Kim,C.H., Kim,J.H., Hsu,C.Y. and Ahn,Y.S. (1999) Zinc is required in pyrrolidine dithiocarbamate inhibition of NF-kappaB activation. FEBS Lett., 449, 28-32.
56. Prasad,A.S., Bao,B., Beck,F.W. and Sarkar,F.H. (2001) Zinc activates NFkappaB in HUT-78 cells. J. Lab. Clin. Med., 138, 250-256.
57. Jeon,K.I., Jeong,J.Y. and Jue,D.M. (2000) Thiol-reactive metal compounds inhibit NF-kappa B activation by blocking I kappa B kinase. J. Immunol., 164, 5981-5989.
58. Gasparian,A.V., Yao,Y.J., Lu,J., Yemelyanov,A.Y., Lyakh,L.A., Slaga,T.J. and Budunova,I.V. (2002) Selenium compounds inhibit I kappa B kinase (IKK) and nuclear factor-kappa B (NF-kappa B) in prostate cancer cells. Mol. Cancer Ther., 1, 1079-1087.
59. Andela,V.B., Schwarz,E.M., Puzas,J.E., O'Keefe,R.J. and Rosier,R.N. (2000) Tumor metastasis and the reciprocal regulation of prometastatic and antimetastatic factors by nuclear factor kappaB. Cancer Res., 60, 6557-6562.
60. Levine,L., Lucci,J.A. III, Pazdrak,B., Cheng,J.Z., Guo,Y.S.,Townsend,C.M. Jr and Hellmich,M.R. (2003) Bombesin stimulates nuclear factor kappa B activation and expression of proangiogenic factors in prostate cancer cells. Cancer Res., 63, 3495-3502.
61. Shukla,S., MacLennan,G.T., Fu,P., Patel,J., Marengo,S.R., Resnick,M.I. and Gupta,S. (2004) Nuclear factor-kappaB/p65 (Rel A) is constitutively activated in human prostate adenocarcinoma and correlates with disease progression. Neoplasia, 6, 390-400.
62. Kambe,T., Yamaguchi-Iwai,Y., Sasaki,R. and Nagao,M. (2004) Overview of mammalian zinc transporters. Cell. Mol. Life Sci., 61, 49-68.
63. Hasumi,M., Suzuki,K., Matsui,H., Koike,H., Ito,K. and Yamanaka,H. (2003) Regulation of metallothionein and zinc transporter expression in human prostate cancer cells and tissues. Cancer Lett., 200, 187-195.
64. Rishi,I., Baidouri,H., Abbasi,J.A., Bullard-Dillard,R., Kajdacsy-Balla,A., Pestaner,J.P., Skacel,M., Tubbs,R. and Bagasra,O. (2003) Prostate cancer in African American men is associated with downregulation of zinc transporters. Appl. Immunohistochem. Mol. Morphol., 11, 253-260.